Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28828697
Publication Date : 2017/08/22

Metacognitive training in patients recovering from a first psychosis: an experience sampling study testing treatment effects.


Cognitive biases, negative affect and negative self-esteem are associated with paranoia in people with psychotic disorders. Metacognitive group training (MCT) aims to target these biases although research has shown mixed results. Our objective was to establish the effect of MCT on paranoid ideation in patients with recent onset psychosis in a powerful experience sampling design. 50 patients between the age of 18 and 35 were included in a single-blind, parallel group RCT comparing MCT with occupational therapy (OT) as an active control condition. We assessed via questionnaires and experience sampling treatment effects on paranoid ideation, delusional conviction, the cognitive bias jumping to conclusion (JTC), and cognitive insight, as well as treatment effects on associations between negative affect, negative self-esteem and paranoid ideation. Patients in the MCT group did not show a decrease in paranoid ideation, delusional conviction, JTC-bias or an increase in cognitive insight compared with OT. However, negative affect showed a weaker association with paranoid ideation post-treatment in the MCT condition. In the OT condition, this association was stronger post-treatment. We tentatively suggest that patients with an early psychosis seemed to benefit from MCT in emotional learning compared with the OT condition. Despite the fact that the group training is well-received by patients, subsequent individual MCT (MCT+) may be indicated for stronger favorable effects on paranoid ideation.

Authors : Pos Karin , Meijer Carin J , Verkerk Oukje , Ackema Onno , Krabbendam Lydia , de Haan Lieuwe ,

Related products :

Catalog number Product name Quantity
30-204 Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are med 0.1 mg
B438 Brain Heart Infusion w_PABA & Agar USE : For improved growth of pathogens from blood from patients undergoing sulphonamide treatment. 5x500gm
B438 Brain Heart Infusion w_PABA & Agar USE For improved growth of pathogens from blood from patients undergoing sulphonamide treatment. Qty per Litre of Medium: 38
orb61200 17-AAG 17-N-Allylamino-17-demethoxygeldanamycin is a derivative of the antibiotic geldanamycin that is being studied in the treatment of cancer, specific young patients with certain types of leukemia 250 mg
KMS05 The training model for blood testing Set
orb60920 Silymarin Silymarin(Silybin B), a strong novel free radical scavenger, is used for treatment of patients with acute brain infarction. For research use only. 10 mg
KMS05 The training model for blood testing, Natural size
orb61239 Dasatinib Dasatinib is an oral multi- BCR_ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML) after imatinib treatment and Philadelphia ch 100 mg
800108 Device for sterile sampling (support, glass sampling device, syringe filter, 3 clamps and tubing)
orb61280 PF-02341066 Crizotinib is an ALK (anaplastic lymphoma kinase) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US, and undergoing clinical trials testing its safe 10 mg
MD80001 MagCustom Feasibility Study, Bead development on client demand in small scale as feasability study 1 item
orb60893 Matrine((+)-Matrine) Matrine((+)-Matrine) is an alkaloid found in plants from the Sophora family. It has a variety of pharmacological effects, including anti-cancer effects, and action as a kappa opio 50 mg
B1275 Universal Pre-enrichment Broth USE : For recovering sublethally injured Salmonella and Listeria from food products. 5x500gm
B1275 Universal Pre_enrichment Broth USE For recovering sublethally injured Salmonella and Listeria from food products. Qty per Litre of Medium: 38,05
orb60289 Amisulpride Amisulpride is an atypical antipsychotic used to treat psychosis in schizophrenia and episodes of mania in bipolar disorder. For research use only. 100 mg
B268 NIH Agar Medium USE : For sterility testing and for cultivation and maintenance of isolates from sterility testing of biological products. 5x500gm
TM1186 FLUCONAZOLE TESTING MEDIUM (DOUBLE PACK) (Store below 8º C) (for fluconazole susceptibility testing by using Candida species ) 100 gm
B268 NIH Agar Medium USE For sterility testing and for cultivation and maintenance of isolates from sterility testing of biological products. Qty per Litre of Medium: 43
TM1186 FLUCONAZOLE TESTING MEDIUM (DOUBLE PACK) (Store below 8º C) (for fluconazole susceptibility testing by using Candida species ) 500 gm
73827-11 GAS SAMPLING TUBE 500 ML Case of 1
653150-0250 GAS SAMPLING TUBE 250 ML Case Qty: 1
653150-0500 GAS SAMPLING TUBE 500 ML Case Qty: 1
BSP-ALL A sampling of each type of bead in a 10 mL tube
653150-0125 GAS SAMPLING TUBE 125 ML Case Qty: 1
653150-0250 GAS SAMPLING TUBE 125 ML Case of 1


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur